Huang, Qingyu
Dou, Xue
Liu, Jing
Feng, Rui
Zhang, Xiang
Yue, Jinbo
Funding for this research was provided by:
National Natural Science Foundation of China (82272753)
Science Fund for Distinguished Young Scholars of Shandong Province (ZR2021LZL002)
Bethune Cancer Radiotherapy Translational Medicine Research Fund (flzh202103)
The Key Research and Development Program of Shandong (2021SFGC05012021)
Article History
Received: 26 July 2024
Accepted: 4 June 2025
First Online: 1 July 2025
Declarations
:
: The Ethics Committee of Shandong Cancer Hospital confirmed that ethical approval was not required for this study (SDTHEC201803027). Participants were informed that their data would be gathered and used for this study; all participants gave their informed consent to participate in the present study. All methods were performed in accordance with the relevant guidelines and regulations, and this study adhered to the principles outlined in the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.